<![CDATA[Weil Lab - News]]>Sat, 08 Aug 2026 14:00:14 -0700Weebly<![CDATA[B. fragillis toxin manuscript preprint posted!   https://www.biorxiv.org/content/10.64898/2026.06.22.733822v1B]]>Thu, 09 Jul 2026 17:29:51 GMThttps://weillab.weebly.com/news/b-fragillis-toxin-manuscript-preprint-posted-httpswwwbiorxivorgcontent106489820260622733822v1b
Picture
]]><![CDATA[Ana and Denise attend the U.S.-Japan Cooperative Medical Sciences Program Boot Camp 2026! Tokyo Jan 15-16]]>Thu, 08 Jan 2026 20:16:00 GMThttps://weillab.weebly.com/news/ana-and-denise-head-to-tokyo-for-the-us-japan-cooperative-medical-sciences-program-boot-camp-2026-jan-14-15
Picture
Denise giving the WINNING PRESENTATION for her group!!!!
Picture
Picture
Tokyo subways since we stayed in a few different locations for this meeting!
]]><![CDATA[CONGRATS to DENISE for Nature Communications acceptance!]]>Thu, 30 Oct 2025 23:23:10 GMThttps://weillab.weebly.com/news/congrats-to-denise-for-nature-communications-acceptanceDr. Denise Chac's work from her time as a T32-funded post-doctoral student has been accepted. Link to come!

Abstract: The degree of protection conferred after receiving an oral cholera vaccine (OCV) varies based on age, prior exposure to Vibrio cholerae, and unknown factors. Recent evidence suggests that the microbiota may mediate some of the unexplained differences in oral vaccine responses. We used metagenomic sequencing of the microbiota at the time of vaccination, and then related microbial features to immune responses after OCV using a reference-independent gene-level analysis. We found that the presence of sphingolipid-producing bacteria was associated with the development of protective immune responses after OCV. We experimentally tested these results by stimulating human macrophages with Bacteroides xylanisolvens metabolites and found that sphingolipid-containing extracts increased innate immune responses to OCV antigens. Our findings demonstrate a new analytic method for translating metagenomic sequencing data into strain-specific results associated with a biological outcome, and in validating this tool, we identified that microbe-derived sphingolipids impact in vitro immune responses to OCV antigens.

]]><![CDATA[Weil Lab will be at ASTMH 2025! Nov 9-13 in Toronto, Canada]]>Mon, 27 Oct 2025 16:26:58 GMThttps://weillab.weebly.com/news/weil-lab-will-be-at-astmh-2025-nov-9-13-in-torotonSusan and Ana will be attending the ASTMH annual conference this year in Toronto at the Metro Toronto Convention Centre Toronto, Ontario, Canada. Susan will be presenting a poster on her research on the Emerging Pathogens Initiative (EPI) project and Ana will be presenting a poster on our new transwell assays with enteric pathogens. ]]><![CDATA[V. cholerae chromosome fusion paper published! Congrats to Aline.]]>Fri, 25 Jul 2025 18:05:50 GMThttps://weillab.weebly.com/news/v-cholerae-chromosome-fusion-paper-published-congrats-to-aline
Picture
]]><![CDATA[Ana's Boston Children's Hospital invited talk 1/22/2025]]>Mon, 27 Jan 2025 21:46:13 GMThttps://weillab.weebly.com/news/anas-boston-childrens-hospital-invited-talk-1222025
Picture
Ana spoke on Thursday January 22nd about V. cholerae infection and the microbiota impact on severity of disease, and on how microbe-derived sphingolipids may modulate oral cholera vaccine responses
]]><![CDATA[Denise's Haiti paper is published!]]>Fri, 02 Aug 2024 22:36:27 GMThttps://weillab.weebly.com/news/denises-haiti-paper-is-publishedFull manuscript here
Picture
]]><![CDATA[Amelia Rice, summer student]]>Fri, 02 Aug 2024 22:32:45 GMThttps://weillab.weebly.com/news/amelia-visits-for-the-summer
Picture
Learn more here about Amelia and her work
]]><![CDATA[US-Japan Joint Panel Conference on Cholera and Other Bacterial Enteric Infections]]>Tue, 12 Sep 2023 21:43:21 GMThttps://weillab.weebly.com/news/us-japan-joint-panel-conference-on-cholera-and-other-bacterial-enteric-infectionsOkinawa, Japan Dec 12-14, 2023

Ana and Denise were invited to present!

Ana: Host-microbe interactions between gut microbes and Vibrio cholerae

Denise: Improved human-derived models for measuring immune response to oral cholera vaccine antigens
]]><![CDATA[HHMI Emerging Pathogens Initiative - new project]]>Tue, 12 Sep 2023 21:35:33 GMThttps://weillab.weebly.com/news/hhmi-emerging-pathogens-initiative-new-projectIn collaboration with the laboratories of Dr. Joseph Mougous and Guarav Bhardwaj!

We will be targeting enteric pathogens with designed peptides to block virulence! Check it out here
]]>